Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hub-And-Spoke Pioneer PureTech's Strategy Paying Off

Insights From CEO Daphne Zohar

10 Jun 2021

• By Kevin Grogan

Zohar_Daphne.1200 — Daphne Zohar • Source: PureTech

Related Content

Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model

18 Feb 2021

Finance Watch: Roivant To Go Public In SPAC Merger, Raise $611m

03 May 2021

Karuna Upbeat On New Antipsychotic Mechanism Data

19 Nov 2019

Gelesis's Obesity Product FDA Acceptance Gives Boost To PureTech's Portfolio

15 Apr 2019

Gaming For Attention: FDA Grants De Novo For Novel ADHD Treatment

16 Jun 2020

Related Companies

BridgeBio Pharma, Inc.

Roivant Sciences Ltd.

Centessa Pharmaceuticals plc

PureTech Health plc

Gelesis, Inc.

Merck & Co., Inc.

Sanofi

Pfizer Inc.

Nimbus Therapeutics, Inc.

Roche Holding AG

Sage Therapeutics, Inc.

Karuna Therapeutics, Inc.

Follica Inc.

Vor Biopharma Inc.

Additional Topics

Companies Strategy Leadership Commercial BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.